23s2s

✏️ Editing: 1772295306.M527211P5099.mgh-web11.maghost.ro,S=14058,W=14285

Envelope-to: webmaster@globalnetworking.net
Delivery-date: Sat, 28 Feb 2026 18:15:06 +0200
Date: Sat, 28 Feb 2026 17:14:12 +0100
Subject: Top Mayo Clinic Researcher Says "Relieve Your Neuropathy Pain in 3 Days".
From: 'Neuropathy Pain Relief' <Relief-4X0@YellowVitaminTVgdVJyrn.com>
To: "webmaster@globalnetworking.net" <webmaster@globalnetworking.net>
Auto-Submitted: auto-generated
X-MS-Exchange-CrossTenant-OriginalArrivalTime: Tue, 02 Dec 2025 16:25:44 +0100
 (UTC)
 =?utf-8?Q?F0wmmI3i+eQwNM1RMBTOmi81iTo99pz4e0Y=3D?=
Content-Transfer-Encoding: 7bit
Content-Type: text/html; charset=UTF-8
X-Send-Method: smtp
X-Hostname: mail.mta7145.ogwkyzzdz.org
X-ClientProxiedBy: SA0PR11CA0101.namprd11.prod.outlook.com
 (2603:10b6:806:d1::16) To YQBPR0101MB9838.CANPRD01.PROD.OUTLOOK.COM
 (2603:10b6:c01:7a::17)
MIME-Version: 1.0
X-MS-PublicTrafficType: Email
X-MS-Office365-Filtering-Correlation-Id-Prvs:
	5b7fcbc5-b955-423a-80b0-08dce9114030
X-MS-Exchange-SenderADCheck: 1
X-MS-Exchange-AntiSpam-Relay: 0
X-Microsoft-Antispam-Message-Info:
	=?utf-8?B?OHQ5anVPQWFMZHRsWE43T0Q4YjRSS1Q5bi9UTWFiYzdnWnFLSDZHcytaZGFw?=
 =?utf-8?B?bE51c0Y4dktIU24vQkVzUHRHQVYzZkFRNVhkbS9udTZaa2piL25sQXVkdnVL?=
 =?utf-8?B?ZE56ZzUzcjcxTnBOcGY3UURuU0tKM3hKdVRxTVV3NFFBS3gwLzBWRHF4Rjc5?=
 =?utf-8?B?VUdCeXFpQk91WFRITUFLZEloWmhManpXQU1WQVE3dTVGcmJ2SEJ0WWpIRGJq?=
 =?utf-8?B?UmMwNWswbngzdHZxbVRoeE9NVGtxMGE2V044c3FHV25PeEdYNVBrMlFoNFhq?=
 =?utf-8?B?YWp0c0pzNWREdXQ2UERKdHdkSVYxUi9CRm43d1RwTjhTSEtFTTVXOFhLRGFi?=
 =?utf-8?B?eTRwWDV4dW84U0IxOC9Kemc5cVBqcXhJUWNmRmFxWG92RXlHMmZVUlZPUE53?=
 =?utf-8?B?S0V3OFpiT0tydVhTVXQrNHRDbGN0QUdzb2gwSnBNc1JLcHhGOW9LQ1hSczda?=
 =?utf-8?B?QVBYV1NtaDY0V00rMGJrYWJ0MUV6bUNYYm9QVmNTSEUvV1FWRDNPQkp4MGlV?=
 =?utf-8?B?bWJpMWd6blZibEwwTkE4aFl0UXExYzBUTENOOVNwSWE5cEpnL0NhbUtOK0Fz?=
 =?utf-8?B?bHJtM0FFRHhYWGZ0QzBjQ0tUcksxMTZMd3p4MENwdHphanpQZUFDMW5GYnhl?=
 =?utf-8?B?NDIxb2FhUk8wallmMWlKTTJublZIWlk0OGhWRVRya05ORmF5L3JibllWSHp2?=
 =?utf-8?B?TWl5ampYM3M3dExIS2V0U2tHOVdzN29KK0NtZ0gvQmFMYktaQmxWbWdUSUh0?=
 =?utf-8?B?WlUzeDY2Y005cEdSdUc4dkJBMGJaNVduK1ZlejlzYVNORnpZWElqUjFsSnBF?=
 =?utf-8?B?ZTFaOXpyMkFPbENNM05kakdPdGJBbll5RUgxZzV5UEx6VGlEd2VEM01ueUVW?=
 =?utf-8?B?OWNNcnBhZmIybWQwaldUUXhKbEtPZVI1dSt0U0txVmVwYzFHUk1MbWpRV2dT?=
 =?utf-8?B?WkNlTW9iK0Uvc2JsdmVXS1BpTmlWVVRJYXFOTVAxK3A5MCs4NGhwZmVnd3Z5?=
 =?utf-8?B?UGtGVnN4YjUrYkFzeTlOWkFJdG1SNmQ4S3JLUVlTL0x6NVMrbmdHSDQ2bXNx?=
 =?utf-8?B?Q2FsU2hGQjJpenlqUldtdFhUMms2SmZBU2tZL1VuaVE1ajQ4b3d5R0JRRUtu?=
 =?utf-8?B?VEtiYlV2NWlXSmV3NzlzYVdnZnFOYTQ1blBHNFdUZklSMGdvbHRBcjZLMDVv?=
 =?utf-8?B?ak1VUGdRanowdTNveExiSS9IaHNqK3E5RHFyL0pGZXM1aUdyaFV2RmhpNktz?=
 =?utf-8?B?by83eEVXZndkMHkwVWZmWW5KeCtNb1ZZMkN6d28vQ253RzJYdVRKNFdsVzV2?=
 =?utf-8?B?ZFdLUGpKSnBkaUNMMmhVVWZzaEZDb3NLRFdxR3h0Njg2aExFMTZjZEs5NWg5?=
 =?utf-8?B?L3BZMzZhdTkrVXVUOHhMSU1qNHNBanltWm83RlZPeUQzdUM2VHg5SGhZVDZr?=
 =?utf-8?B?SWN5MmFxMS95cWE2NDdBUE5ZVlM3c250azd4MGtoMXlZTFUzcmdQT1RwZG5s?=
 =?utf-8?B?UHZqaE9sMVNLVnJBK0kxU2dBMDJuZ2lCMUlDdzlKL2JsZWtYVnpBc29md1li?=
 =?utf-8?B?Vjg0L3c3S1NZVHA1Qi83SGkyeDExdkl5ZW9OeTFmN0dOclMweUhNeFJWVzRt?=
 =?utf-8?B?VG13aWoxaHNBbjJYeDlQWG1tdGlwTGc9PQ==?=
X-Forefront-Antispam-Report:
	CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:YQBPR0101MB9838.CANPRD01.PROD.OUTLOOK.COM;PTR:;CAT:NONE;SFS:(13230040)(14060799003)(366016)(376014)(69100299015)(52116014)(1800799024)(1032899013)(35042699022)(8096899003)(3613699012)(2066899003)(38350700014)(4076899003);DIR:OUT;SFP:1102;
X-MS-Exchange-AntiSpam-MessageData-ChunkCount: 1
X-MS-Exchange-AntiSpam-MessageData-0:
	=?utf-8?B?SktkV01GZWQ0akNmeXpBUEgxR3lPMktSaU04SThkQktCdzhaUzN3TTlLMkNv?=
 =?utf-8?B?eUV1SWcvbC9za1k5dU1jdjJMVURDT2h1THg0bGUyN0h6b21PdElWWmp0clYv?=
 =?utf-8?B?RS9aS1EyV0F4WERmRklmbkdmZHpsN3pYRk9SZzd4RWtRSGQweC82UTFpMWVy?=
 =?utf-8?B?RGcrd2g5VUpVOGNZaWd1OWljODhTY0h0L3RLTUJvck1qOG5xbDhtZ3hhQVRC?=
 =?utf-8?B?V0dxdmxnRVV6SHE3dDdsU1Z3eEtoajd0NVZXaDRWYUdodml2c3V4UVl4UlNx?=
 =?utf-8?B?U0c4OUo5WUpoQ3pWMXoyZDVYK3NaSko5SXovR0laYjRpalZiYk9INk90WENV?=
 =?utf-8?B?aFpEQnhhdnJzV2w4cDBNd2IvSGg4SmtkQ3l2NzFwZEhoSmVzMFJudU5NS1FM?=
 =?utf-8?B?RXJUbkRoaDF5VFY0OWNpMlhTZVk1a0lkVVBSbVM0TWtDMndCTE4wZWJGWDZt?=
 =?utf-8?B?cVN5VkFyMHJkazV5ZlJNVjZ2S3pNQ1hiWkh0UXVlTXExOTRRUzZpWXlkUXl3?=
 =?utf-8?B?VGJVTkVkNDArYzdTYTFaVjZXUUJtWk5lNXpsTnl1VXdkWm5vUXBxcjdIWGNu?=
 =?utf-8?B?alE2cU9mTFlvanBIbE5qOGJrSlV3OXpSclkzN3Z3QmdUYWFGbHFRY2VSbFBO?=
 =?utf-8?B?cFFEbnJFamFxOGl3d212cDR1dk9paGhPdDhwNmdyK1pJWHFNMWNuSys0bHNK?=
 =?utf-8?B?VS9YeDZMemc5WGVpMlQ2dGxOaUpsaE9OQ0VSNnpEN3U2S3BXV29WQ04vaDQ4?=
 =?utf-8?B?elFMVzh5cjArQjc1aUNpWjF3V1AveUJpa3FqcVhGQmJRa29KL2RFV2RiYk1x?=
 =?utf-8?B?Rk8zaitaVXkyc0xQYVk1WkZsZ0thTXBWdzZwMXkvTWIvRWFFd2FYaEJwUktM?=
 =?utf-8?B?bTQ5MW9xTFljZGI0NmhxQ3ZZSDJ4V20rK0kxUCtJaGc4WnU4UTQ1L3FTZTBD?=
 =?utf-8?B?THJ0a2ZmOHF4cVlFSzFzQ0g4VCtuUDZyY2xOVk42eVk5OW5qa3AxVjNDN0Fi?=
 =?utf-8?B?NDdTSnVDUUpqdThxU3RxNFZmVzBjWUJaWnBSTWUydURLQ0JmRU05V1lXbnZu?=
 =?utf-8?B?Z0t6VUhQbURSL1FjUWxzZEI5NEhBdzNRcCtUM1RZWUl5ZnhkUWFDNmFTS0pX?=
 =?utf-8?B?T2cyNXhjLzdiRE5vaEhIUGFDVTRKNWN3YWRwNDM4d0o2VjU4L21LSHkvakcr?=
 =?utf-8?B?SDFPNzJWZHZVcVIrb1YrMVVySFZ3UjFxWUozMElMQmVDR3FCbENGdThHYVhH?=
 =?utf-8?B?SVQwd0lkQzJZcC9ET0dSczhKUFhIb25BU1FqTnVydG16RWZvWGdEV2RDRzlu?=
 =?utf-8?B?dUtBYmxGeHRwQmh6MklZQzVvWTZBWFdnWHU2OCtJZWtxK0htdFlKTU9mTlE4?=
 =?utf-8?B?ZGphNG90cFRMbnNRWkVhOHNUZkYyWnZXa0s2aGtBMjVwNWJ5bUlNUk9PWUdD?=
 =?utf-8?B?VnZDRXBxMGhVOS9XU1NlWWorUVM0b01kclAvZ2ZRYnVWcWdYMkpMc0NPL29E?=
 =?utf-8?B?RXV0NjIvMjZHbDZ2NGtjNER4Q2thd0VDeEx0aFpaMFIrblI2YTFuN1lBVEJl?=
 =?utf-8?B?aWI0RFRGRVZYdklKUENzVG1jL1l3eXlGT20wWTA4MEZldEFlRW9YeW5jMERD?=
 =?utf-8?B?c0dKK0wvaXB4SlRMeGt2RGZDOGw4eVh2a1plSkhFNVdVLzQva2s5UjNmdUFJ?=
 =?utf-8?B?WXZYZkVHa2lBYi9rYytPWEp6QjVWb1Y2RGtXYzJCYVJDQjF6MmsxQ2kveGRB?=
 =?utf-8?B?UlRyUTQ2cVNBOXlXNVRwUm1UZVhxOGtONXVIblg4eVNMZmt4T0haSWJEajRV?=
 =?utf-8?B?M3hOaW9NUjB0NGJRS1RBYS93a05OK2xuT09vYXpkQVJ4SHo5UWU2S096c2ZM?=
 =?utf-8?B?SUoyVmZDaW5TWUt6Yi9xQ1VPTDNEa1NQR0ZqSm5YTm16NFUvUHF3cm5lTlNG?=
 =?utf-8?B?eEttRDk1U0wrS0hNZkhVdXN5NWEvcVFwNC9kYTc4akg5cE8zUG1GNThaNjRt?=
 =?utf-8?B?WUd1T3JWRmlDTkh4KzVKd0ZIMGs0dXhDNG5JM3NzNXFWeGNZY2pIR1hKVzgw?=
 =?utf-8?B?S1NKYy9GOUpNL2RRSDdqajNTWGNYQVRsdS9qamdTRDE1dVJDdjhhcWFZUFFZ?=
 =?utf-8?Q?pWRc=3D?=
X-OriginatorOrg: prolab84.syenurelle.uk
X-MS-Exchange-CrossTenant-Network-Message-Id: 94c906ac-1c50-4637-0f16-08de31b753fb
X-MS-Exchange-CrossTenant-AuthSource: YQBPR0101MB9838.CANPRD01.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 02 Dec 2025 15:27:39.2729
 (UTC)
X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted
X-MS-Exchange-CrossTenant-Id: 83934313-fcdc-41ad-b704-1576d1bd2705
X-MS-Exchange-CrossTenant-MailboxType: HOSTED
X-MS-Exchange-CrossTenant-UserPrincipalName: +FJNaAKvv/ES6JVmTMiYtAsiyZnbQLiPUpIq31H8RO/HaKo0cDAxRiIneIegKp39sgYkDFHd4U+3Jn31o7zGoe40fkqXBu4+q12+ukiuVELVsWs4TVEtuN4Cy1Nk4HQJ
X-MS-Exchange-Transport-CrossTenantHeadersStamped: YT3PR01MB8625
X-Vade-Verdict: clean
X-Vade-Analysis-1: dmFkZTFB2BdE4qM6kYzzIdJNe8XRtXTUosvquyWzJ9WtC0/MRlP7g0cHaZCMvq0fHfvn00UrgtoXVWkk
X-Vade-Analysis-2: SN9okNRmzGAp9nhlfsEOlNsdqaWhKQIpqkiflp9auz4KUuYWA1Z4dbd10IApY+ZOr55Uj5WT9zhD0cyL
X-Vade-Analysis-3: SigQWuUH22EJuDlOIV83PQbO5mmJvYJrPo+iTCb+H4PHtjxaguliYfgKOHITb9fzp5EZSbZNC28vj5T4
X-Vade-Analysis-4: rGyrTaraiLePFNd3ZYnpPlL1TvkSBOacGjbVAHPsjpI1IxoHYxKZElZ8IuN8aXOHaGwaL89jJ89n7ugK
X-Vade-Analysis-5: 9MD97TPMNh3tapKQIw2N2f/ON0eTOFk5LVpAoNY1291pRDNu8H2hmQq7azWP/wJEQrgXNAG51um2vuZC
X-Vade-Analysis-6: abLCjbF6qJ84cTtgGj3g9vawBRiq1PUcyrzA2SioBn0WyUwGs1Iu5eDSrszF+RNiEmWFRHHfTtHALJ4a
X-Vade-Analysis-7: eFdBNG5oDTH2wMnb3RR2nuIINkitMgvfsuDhneDYChGq8bU8cU/MginSA1jUcFgaOMW8T/Qt9jBXoDtv
X-Vade-Analysis-8: aNeEkQEiiCeVtouQxaGcsTXnS8J9kTElhV3TRAkNIAe/gkl1muFsxSwNgay/UaR9mhV+8K4w5D+e1A6c
X-Vade-Analysis-9: fXqezc3u9daBiGFwjkq5/PX4+XePmjZn6ni8K4x2pSKCxKXsGw

<!DOCTYPE html>
<html lang="en">
 <head> 
  <meta charset="UTF-8" /> 
  <meta name="viewport" content="width=device-width, initial-scale=1.0" /> 
  <title>Document</title> 
  <style>
    body {
        max-width: 600px;
        padding-left: 15px;
        display: block;
    }

.main {
        max-width: 100%;
        display: block;
        font-family: Arial, Helvetica, sans-serif;
        font-size: 1.2rem;
        text-align: left;
    }

.hero {
        max-width: 100%;
        display: block;
    }

.footer {
        max-width: 100%;
        display: block;
        font-family: Arial, Helvetica, sans-serif;
        font-size: .8rem;
        text-align: left;
        padding-top: 50px;
    }

</style>
 </head>  
 <body> 
  <div class="main">
    Recent studies from the Karolinska Institute in Sweden have discovered 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=cl&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769"><strong>a specific vitamin that targets the root cause of nerve inflammation caused by neuropathy.</strong></a>
   <br />
   <br /> These studies refer to a molecule known as 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=cl&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769"><strong>"Pain Molecules,"</strong></a> which accumulate around your nerves and cause those dreaded neuropathy pains.
   <br />
   <br /> Which vitamin do you think would be most effective in the fight against the 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=cl&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769"><strong>"Pain Molecule,"</strong></a> permanently eradicating inflammation?
   <br />
   <br /> 
   <ul> 
    <li>Vitamin C</li> 
    <li>Vitamin D</li> 
    <li>Vitamin B</li> 
    <li>Yellow Vitamin</li> 
   </ul>
   <br /> 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=cl&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769"><strong>The answer will surprise you! Watch this brief video explanation</strong></a>, and then come back to thank me!
   <br />
   <br /> If you want to learn more about the yellow vitamin and the pain molecule, 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=cl&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769"><strong>check out this free presentation here</strong></a>. 
  </div> 
  <div class="footer">
    C/O Biofraga 19655 E 35th Drive. Suite 100 Aurora, CO 80011
   <br /> 
   <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=un&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769">Unsubscribe</a> 
  </div>  
 </body>
</html>
<br/><br/><span style="color:#888;font-size:11px;font-family:verdana;display:block;text-align:center;margin-top:10px">click <a href="https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=oop&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769">here</a> to remove yourself from our emails list</span><br/><br/><img alt='' src='https://storage.googleapis.com/4b6eb384d1a9d5858a49/ac532f4456afc102fd56#?act=op&pid=623_md&uid=1&vid=317&ofid=416&lid=710&cid=611769' width='1px' height='1px' style='visibility:hidden'/>

Sid Gifari From Gifari Industries - BD Cyber Security Team